Liver Test Interpretation and Workup
The R-ratio framework that turns abnormal liver tests into a diagnosis: hepatocellular, cholestatic, or mixed pattern, then the noninvasive fibrosis tools FIB-4 and FibroScan with etiology-specific cutoffs. Biopsy indications, plus the workup ladder for AIH, hereditary hemochromatosis, Wilson disease, PBC, and PSC.
- Audio chapterAttending-narrated, listen on the commute.
- ABIM-format MCQs5-option vignettes with full wrong-answer teaching.
- Study guideTables, decision trees, primary sources.
- AI tutorChapter-grounded, answers the question you're stuck on.
What this chapter covers
- Section 17.1: Pattern recognition and the R ratio
Abnormal liver tests are not a diagnosis.
- Section 17.2: Hepatocellular workup
A patient with hepatocellular injury (R over 5) gets a layered workup that is sequenced by pretest probability and reversibility.
- Section 17.3: Cholestatic workup
Cholestatic injury (R under 2) splits cleanly along an imaging-first line, because the workup branches at whether the biliary tree is dilated.
- Section 17.4: Isolated hyperbilirubinemia
A patient with elevated bilirubin and otherwise normal aminotransferases, alkaline phosphatase, albumin, and INR has isolated hyperbilirubinemia, and the workup splits at the very first lab: is the elevation predominantly indirect (unconjugated) or direct (conjugated)?
- Section 17.5: Isolated alkaline phosphatase elevation
Alkaline phosphatase comes from multiple tissues and an isolated elevation does not necessarily mean liver disease.
- Section 17.6: Imaging modalities and noninvasive fibrosis
Noninvasive assessment of liver disease has restructured hepatology over the last 15 years, and the boards expect candidates to know which test answers which question and at what cutoff.
- Section 17.7: Liver biopsy indications and techniques
Liver biopsy has narrowed in indication as noninvasive tools have improved, but it remains the answer when staging is uncertain, when overlapping diagnoses cannot be separated by serology, when the etiology is unclear after a complete biochemical and noninvasive workup, and when transjugular access provides additional hemodynamic information that imaging alone cannot supply.
Podcast episodes
- 01
The R Ratio and the Two Workup Tracks
Abnormal liver tests are a screening signal, not a diagnosis. Compute the R ratio first, commit to a track, then run the hepatocellular workup in order (viral, autoimmune, metabolic, ischemic, drug) or the cholestatic workup off a single imaging question: is the biliary tree dilated?
- 02
Isolated Abnormalities, Imaging, and Biopsy
What to do when the pattern is a single abnormality or the labs alone aren't enough: isolated unconjugated versus conjugated hyperbilirubinemia, an isolated alkaline phosphatase sorted by GGT before any cholestatic workup, the noninvasive fibrosis tools, and the biopsy indications where tissue still changes management.